---
title: "山东威高集团医用高分子制品股份有限公司 (01066.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/01066.HK.md"
symbol: "01066.HK"
name: "山东威高集团医用高分子制品股份有限公司"
industry: "医疗用品"
---

# 山东威高集团医用高分子制品股份有限公司 (01066.HK)

| Item | Detail |
|------|--------|
| Industry | 医疗用品 |
| Location | 港股市场 |
| Website | [www.weigaogroup.com](https://www.weigaogroup.com) |

## Company Profile

山东威高集团医用高分子制品股份有限公司主要从事一次性医用产品的研发、生产及销售业务。该公司通过其自有品牌 “洁瑞” 和 “威高骨科” 销售产品。该公司通过三个业务分部进行运营。一次性医疗器械产品分部生产及销售一次性使用耗材，如输液器、注射器及血袋。骨科产品分部生产及销售骨科产品。血液净化产品分部生产及销售血液净化产品及相关医疗设备。该公司也通过其子公司制造工业自动化设备及部件，以及提供物流仓储服务。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-16T04:30:10.000Z

**Overall: C (0.43)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 5 / 12 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 1.14% |  |
| Net Profit YoY | 3.07% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.89 |  |
| Dividend Ratio | 4.65% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 23.55B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 14.20B |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 8.34% | B |
| Profit Margin | 15.02% | A |
| Gross Margin | 49.72% | B |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 1.14% | C |
| Net Profit YoY | 3.07% | C |
| Total Assets YoY | 6.58% | B |
| Net Assets YoY | 6.25% | B |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 665.61% | C |
| OCF YoY | 1.14% | C |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.37 | C |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 28.91% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 山东威高集团医用高分子制品股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "8.34%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "15.02%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "49.72%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "1.14%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "3.07%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "6.58%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "6.25%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "665.61%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "1.14%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.37",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "28.91%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 康耐特光学 (HK.2276) | A | B | B | B | B | B |
| 02 | 中国同辐 (HK.1763) | B | B | C | C | B | B |
| 03 | 瑛泰医疗 (HK.1501) | B | B | C | B | B | B |
| 04 | 业聚医疗 (HK.6929) | B | B | C | A | C | B |
| 05 | 威高股份 (HK.1066) | B | C | C | B | C | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 10.73 | 2/12 | 12.46 | 11.77 | 11.14 |
| PB | 0.88 | 5/12 | 1.07 | 0.98 | 0.92 |
| PS (TTM) | 1.61 | 6/12 | 1.95 | 1.81 | 1.67 |
| Dividend Yield | 4.74% | 2/12 | 4.47% | 4.01% | 3.58% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-04T16:00:00.000Z

Total Analysts: **10**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 8 | 80% |
| Overweight | 1 | 10% |
| Hold | 1 | 10% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.11 |
| Highest Target | 8.39 |
| Lowest Target | 6.02 |

## References

- [Company Overview](https://longbridge.com/en/quote/01066.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/01066.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/01066.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.